CC BY-NC-ND 4.0 · Laryngorhinootologie 2021; 100(S 02): S103
DOI: 10.1055/s-0041-1727901
Abstracts
Head-Neck-Oncology

Lipid metabolism in head and neck squamous cell carcinoma

L Symeou
1   Universitätsklinikum Regensburg, HNO, Regensburg
,
K Singer
1   Universitätsklinikum Regensburg, HNO, Regensburg
,
I Ugele
1   Universitätsklinikum Regensburg, HNO, Regensburg
,
M Wehrstein
1   Universitätsklinikum Regensburg, HNO, Regensburg
,
P Siska
2   Universitätsklinikum Regensburg, Innere Medizin III, Regensburg
,
M Höring
3   Universitätsklinikum Regensburg, Klinische Chemie und Laboratoriumsmedizin, Regensburg
,
G Liebisch
3   Universitätsklinikum Regensburg, Klinische Chemie und Laboratoriumsmedizin, Regensburg
,
M Kreutz
2   Universitätsklinikum Regensburg, Innere Medizin III, Regensburg
,
C Bohr
1   Universitätsklinikum Regensburg, HNO, Regensburg
› Author Affiliations
› Further Information
Also available at
 
 

    The head and neck squamous cell carcinoma (HNSCC) is one of the most common malignant tumours. New therapeutic strategies target the tumour metabolism. In this regard, this study would analyse the Lipid metabolism of the HNSCC.

    The lipid composition of the tumours and the lipid uptake of tumour-infiltrating immune cells in HNSCC were examined within the scope of the study. The results were compared with the lipid metabolism of corresponding healthy mucosa in 29 patients. The lipid species concentrations were determined by means of direct flow injection analysis (FIA) coupled to triple-quadrupole (QQQ) or Fourier-transform-mass-spectrometry (FTMS).

    This study could show that the concentration of cholesteryl ester (CE) is significantly higher in every localisation of the HNSCC in comparison to the healthy mucosa. Likewise, the concentrations of phosphatidylcholine ether(PC O) in tumours (oral cavity, larynx and hypopharynx) is higher than in healthy mucosa. Ceramide (Cer) was significantly higher in all localisations. Hexosylceramide (HexCer) was significantly higher in all locations with exception of the oral cavity. A lower concentration of mono- to fourfold unsaturated PC O lipids could also be detected in the mucosa. Using flow cytometry, we could not detect any significant differences in the uptake of short-chain fatty acids in the tumor-infiltrating T cells, compared to the T cells in the blood and mucosa.

    A significant difference in the lipid concentration of CE, PC O, Cer and HexCer in the tumour environment to the healthy mucosa could be demonstrated. This different lipid composition could function as biomarkers. The altered lipid metabolism could represent a new specific target therapy for HNSCC therapy.

    Poster-PDF A-1485.pdf


    #

    Conflict of interest

    Der Erstautor gibt keinen Interessenskonflikt an.

    Address for correspondence

    Dr. med. Symeou Luisa
    Universitätsklinikum Regensburg, HNO
    Regensburg

    Publication History

    Article published online:
    13 May 2021

    © 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany